ArticleInternal and emergency medicine2026
Maximum heart rate and mortality in sepsis patients: a retrospective cohort study.
Article in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- State-of-the-art review: ß-blockade in critical illness.Intensive care medicine · 2026Review
- Associations of Heart Rate Trajectories with Mortality and AKI Occurrence in Septic Patients: A Retrospective Study from MIMIC-IV and eICU Databases.Journal of clinical medicine · 2026Article
- Machine learning-based predictive tools and nomogram for in-hospital mortality in critically ill cancer patients: development and external validation using retrospective cohorts.BMC medical informatics and decision making · 2025Article
- Efficacy and safety of heart rate control with esmolol on the incidence and duration of organ failure in predicted severe acute pancreatitis: protocol of a multicenter, open-label, randomized controlled trial.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The effects of maximum heart rate (MHR) on the prognosis of sepsis patients are still being determined, and the most optimal MHR is yet to be recommended. We aimed to determine the association between MHR and 28-day mortality in sepsis patients. A total of 269 patients with sepsis were enrolled in this retrospective cohort study. The patients were all from a 28-bed multi-disciplinary ICU in a tertiary teaching hospital. Relevant information about sepsis patients was extracted according to specific inclusion and exclusion criteria. Examined parameters such as the MHR, blood pressure, laboratory variable, primary disease, and comorbidities were collected. The study outcome was a 28-day death. A Cox proportional hazard model and restricted cubic splines (RCS) were used to elucidate the association between MHR and the 28-day mortality of sepsis patients. Sensitivity analyses were also conducted on our results. Finally, we test and verify our results using a validation cohort from a large public database. In patients with sepsis, the 28-day survivors have the lower MHR than the non-survivors (106 vs. 118, P<0.001). After univariate and multivariate Cox regression analyses, the MHR was significantly correlated with 28-day mortality [hazard ratio 1.013, 95% confidence interval (CI) 1.004-1.022, P = 0.004; hazard ratio 1.013, 95% CI 1.004-1.021, P = 0.004]. The patients in the highest quartile of MHR had a higher risk for 28-day mortality than other patients based on the Kaplan-Meier survival curves (log-rank P<0.001). This correlation remained remarkable in subgroup analysis. A typical U-shaped curve relationship was observed between MHR and the 28-day mortality as a continuous variable using the RCS model. The curve shows that either too high or too low MHR will increase the risk of death. The sepsis patients who had a MHR ranging from approximately 70 to 110 beats per minute (bpm) had the lowest 28-day mortality rate. A similar trend was identified in the validation cohort. High or low MHR was associated with an elevated risk for 28-day mortality in patients with sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.